Holocene Advisors Cuts Stake in Boston Scientific Corporation

Hedge fund reduces holdings in medical device company by nearly half

Mar. 16, 2026 at 10:52am

Got story updates? Submit your updates here. ›

Holocene Advisors LP, a hedge fund, has reduced its stake in Boston Scientific Corporation (NYSE:BSX) by 47.8% in the third quarter, according to a recent SEC filing. The firm now owns 2,950,865 shares of the medical equipment provider's stock, down from 5,657,034 shares previously.

Why it matters

This significant reduction in Holocene's position in Boston Scientific could signal a shift in the hedge fund's investment strategy or outlook on the company. As a major institutional investor, Holocene's trading activity is closely watched by the market and may influence sentiment around Boston Scientific's stock.

The details

According to the SEC filing, Holocene Advisors sold 2,706,169 shares of Boston Scientific during the third quarter. The firm now owns approximately 0.20% of the company's outstanding shares, down from 0.38% previously. The sale comes as Boston Scientific's stock has faced volatility and some analyst downgrades in recent months.

  • Holocene Advisors reduced its stake in Boston Scientific during the third quarter of 2026.

The players

Holocene Advisors LP

A hedge fund that has significantly reduced its position in Boston Scientific Corporation.

Boston Scientific Corporation

A global medical device company that develops and markets a broad portfolio of products used in less-invasive medical procedures.

Got photos? Submit your photos here. ›

The takeaway

This reduction in Holocene's stake in Boston Scientific could signal broader concerns about the company's near-term outlook, as the hedge fund appears to be taking a more cautious approach to its investment. Investors will likely be watching closely to see if other major institutional holders follow suit or if Boston Scientific can regain momentum.